|
|
Blood, 1 February 2008, Vol. 111, No. 3, pp. 1013-1020.
Prepublished online as a Blood First Edition Paper on October 19, 2007; DOI 10.1182/blood-2007-06-096438.
Previous Article | Next Article 
Submitted June 18, 2007
Accepted October 8, 2007
Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway
Kevin M Elias, Arian Laurence*, Todd S Davidson, Geoffrey Stephens, Yuka Kanno, Ethan M Shevach, and John J O'Shea
Howard Hughes Medical Institute National Institutes of Health Research Scholars Program, Bethesda, MD, United States
Lymphocyte Cell Biology Section, Molecular Immunology and Inflammation Branch, NIH/NIAMS, Bethesda, MD, United States
Laboratory of Immunology, Cellular Immunology Section, NIH/ NIAID, Bethesda, MD, United States
* Corresponding author; email: laurencea{at}mail.nih.gov.
CD4+ helper T (Th) cells play a crucial role in the delicate balance between host defense and autoimmune disease. Two important populations of helper T cells are the proinflammatory, interleukin-17-producing (Th17) cells and the anti-inflammatory forkhead box P3 positive (FoxP3+) T regulatory (Treg) cells. Here we show that all-trans retinoic acid (ATRA) and other agonists of the retinoic acid receptor alpha (RAR ) inhibit the formation of Th17 cells and promote FoxP3 expression. Conversely, inhibition of retinoic acid signaling constrains transforming growth factor beta (TGF -1) induction of FoxP3. The effect of ATRA is mediated independent of interleukin 2, signal transducer and activator of transcription (Stat)5 and Stat3, representing a novel mechanism for the induction of FoxP3 in CD4 T cells. As previous studies have shown that vitamin A derivatives are protective in animal models of autoimmune disease, the current data suggest a previously unrecognized role for RAR in the regulation of CD4+ T cell differentiation and provide a mechanism for the anti-inflammatory effects of retinoic acid.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. Muranski, A. Boni, P. A. Antony, L. Cassard, K. R. Irvine, A. Kaiser, C. M. Paulos, D. C. Palmer, C. E. Touloukian, K. Ptak, et al.
Tumor-specific Th17-polarized cells eradicate large established melanoma
Blood,
July 15, 2008;
112(2):
362 - 373.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |